Frontiers Association of Lipoprotein(a)-Associated Mortality and
Por um escritor misterioso
Descrição
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
IJERPH, Free Full-Text
Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies - ScienceDirect
Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population - ScienceDirect
Association of Lipoprotein(a) With Recurrent Ischemic Events Following Percutaneous Coronary Intervention - ScienceDirect
Frontiers Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients
Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks – Consult QD
Lipoprotein(a): The next frontier in CV risk reduction
Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
